康惠制药涨2.01%，成交额825.62万元，主力资金净流入29.59万元

Core Insights - Kanghui Pharmaceutical's stock price increased by 2.01% on September 24, reaching 22.33 CNY per share, with a total market capitalization of 2.23 billion CNY [1] - The company has experienced a year-to-date stock price increase of 55.50%, but has seen a decline of 5.66% over the last five trading days [2] Financial Performance - For the first half of 2025, Kanghui Pharmaceutical reported a revenue of 248 million CNY, a year-on-year decrease of 6.83%, and a net profit attributable to shareholders of -40.20 million CNY, a significant decline of 362.01% [2] - The company has not distributed any dividends in the last three years, with a total payout of 54.23 million CNY since its A-share listing [3] Shareholder Information - As of June 30, the number of shareholders increased by 37.26% to 12,000, while the average number of tradable shares per shareholder decreased by 27.14% to 8,326 shares [2]